The investment and strategic alliance Explain a meeting

 

Creating the hurl industry rises in the last 30 years, achieving many successful enterprises in its development process, identifying to create hurl industry in the global science and technology industry play to push the hand and key role.Bring about the wave tide of global strategic alliance and the merger breeze from 2000 bottom, not only make the manufacture technology industry follow the globalization competition to become the trend that can't avoid, also create again another manufacture technology to invest of new kinetic energy.

Look back 2005, the world accounts USD 20,100,000,000 to come from creating hurl and opens up the funds devotion manufacture technology industries, such as Fu company and the company capital increase...etc., and according to the BioCentury Offerings Databases statistics data manifestation, among them only American a ground of lead to absorb to be close to USD 15,900,000,000 namely, account for 78% of global funds about, European region then for USD 3,260,000,000, account for 16.2% of global funds about, the clearly shows the United States still for nowadays global manufacture technology industry it raise Chu, it has the seed fund of the high risk and creates hurl the fund and mature capital market to inject the manufacture technology industry with the contribution, taking the credit Jue Wei actually.

The American Burrill& Company is for a headquarters to establish in American San Francisco, working on a biotechnology, making a medicine, mankind's health and examining a patient the living creature science commercial bank of the life science realms, such as examination, medical treatment science and technology, the agriculture manufacture technology and the living creature engineering...etc. and creating hurl company exclusively, being well-known very for the world and the financial professional organization of the influence.It is underneath to create the fund scale of[with] the hurl business management to own above over USD 500,000,000 more than 50 of professional employee and more than 20 strategy cooperation the partner use flexibly by providing it with the customer an internal property and enhance and can use a service of operating the capital.

The company's founder and chief executive officer Mr. The G. Steven Burill, in order to have the analysis and observer of the profession and farseeing very much in the biotechnology industry, and hold the post of the Icoria, Pharmasset, the president of Pyxis Genomics and Catalyst Bioisciences, DepoMed, Galapagos Genomics, Targacept and the board director of the Third Wave Technologies etc. company;The manufacture technology company that it guides includes:Amgen, Calgene, Genetech, Chiron, Collagen, Corixa(Anergen), Gilead Science, Insite Vision, SciClone, Terrapin etc. international well-known enterprise.

The American Burrill& Company is aggressive to set up market in Asia, structure Asia and Euro-American manufacture technology industry of network blue print, that company is in addition to establishing base in Mainland China and India, Mr. The G. Steven Burill is this to also come the rate its team in person set, hope looking for the investment and strategic alliance cooperates a partner, building up Taiwan to become one of life science industry strategy centers in its Asia.

This group for push manufacture technology industry actively, establishment and home, outside well-known create a cooperation mechanism of throwing the organization to inject by introducing a funds the Taiwanese manufacture technology industry capital market, create the hurl() company cooperation with the American Burrill& Company and the top Zhi to hold an explanation especially meeting.Welcome with all sincerity each create hurl and industry the forerunner control a first timing, coming to this activity instruction, cooperate with this great project.

 

生醫推動小組業界資訊合作廣宣
本網頁由周國珍負責,如有任何指教地方, 請 email 通知.


經濟部生技醫藥產業發展推動小組全球資訊網
本網站由 經濟部工業局 '生物技術工業發展推動計畫' 專案委辦
電話:02-2655-8133 | 傳真:02-2655-8134
地址:11503台北市南港區園區街三號17樓A室 
 
網頁規劃設計:周國珍先生 indy(at)biopharm.org.tw